Generation Bio Co.: key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2024)
- $19.9M
- Net Income/Loss (FY2024)
- -$131.7M
- Total Assets (FY2024)
- $231.2M
- Total Equity (FY2024)
- $86.2M
- Cash Flows from Operating Activities (FY2024)
- -$88.6M
Source: Generation Bio Co. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
